HGG-16. Final analysis of the HIT-HGG-2007 trial (ISRCTN19852453): Significant survival benefit for pontine and non-pontine pediatric high-grade gliomas in comparison to previous HIT-GBM-C/-D trials.

The aim of the HIT-HGG-2007 trial (ISRCTN19852453) was to demonstrate therapeutic non-inferiority of temozolomide radiochemotherapy for pediatric patients (3-18 years) with high-grade gliomas (pedHGG) in comparison to the cisplatinum-based radiochemotherapy of the two previous clinical trials HIT-GB...

Descripción completa

Detalles Bibliográficos
Autores principales: von Bueren, Andrè O, Kwiecien, Robert, Gielen, Gerrit H, Benesch, Martin, Perwein, Thomas, Nussbaumer, Gunther, Sturm, Dominik, Jones, David T W, Pfister, Stefan M, Eyrich, Matthias, Rutkowski, Stefan, Fleischhack, Gudrun, von Buiren, Miriam, Karremann, Michael, Kortmann, Rolf-Dieter, Hagel, Christian, Calaminus, Gabriele, Faldum, Andreas, Bison, Brigitte, Pietsch, Torsten, Hoffmann, Marion, Kramm, Christof M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
High Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164809/
http://dx.doi.org/10.1093/neuonc/noac079.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164809/
http://dx.doi.org/10.1093/neuonc/noac079.231

Ejemplares similares